Cell 2025

As the cell and gene therapy sector accelerates toward industrial maturity, challenges in manufacturing, regulation, and translational development remain at the forefront. Cell 2025, hosted by Oxford Global, will convene leading experts from across academia, industry, and regulation to discuss how the next generation of tools, technologies, and strategies can transform these therapies from concept to clinic. Among the highlights of the program are keynote presentations from Professor Dame Molly Stevens (University of Oxford), whose pioneering work in bionanoscience is redefining regenerative medicine; Dr Bobby Gaspar (Co-Founder & CEO, Orchard Therapeutics), a leading figure in the translation of gene therapies to the clinic; and Professor Christof von Kalle (Charité and BIH), a global authority in clinical and translational sciences. Cell 2025 is being held on November 11–12, 2025 (with a pre-event focus day on November 10) in London, UK.